ShareValue scores for 300439.SHE: Valuation 58, Quality 51, Growth 30, Health 63.

300439.SHE
SZSE

Ningbo MedicalSystem Biotechnology Co Ltd

CN¥9.25(+6.44%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
58
Fair Value
Price vs Value
Quality
51
Moderate
Business Strength
Growth
30
Weak
Revenue & Earnings
Health
63
Moderate
Financial Stability
Momentum
32
Bearish
Price Trend

Company Details

About

Medicalsystem Biotechnology Co., Ltd. researches, develops, produces, and sells in vitro diagnostic products in China. It is also involved in the provision of third-party medical diagnostic services. The company offers chemiluminescence, biochemistry, integrated combination, TLA system, hematology, point-of-care testing (POCT), mass spectrometry, and blood lipid subfraction analysis. It also provides healthcare services. Medicalsystem Biotechnology Co., Ltd. was formerly known as Ningbo Medicalsystem Biotechnology Co., Ltd. and changed its name to Biotechnology Co., Ltd. in January 2017. The company was founded in 2003 and is based in Ningbo, China. Address: No. 1228, Jinda South Road, Ningbo, China, 315104

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026